TDS Farm, which accounts for 70% of Korean herbal compresses in Korea, to be listed on KOSDAQ in July (Korea)

TDS Farm is a transdermal drug delivery manufacturer that develops and produces a variety of pharmaceuticals, including medicinal patches for muscle and joint pain.
The company plans to list on the KOSDAQ market at the end of July. Its sales in 2023 are expected to reach 30 billion won (approximately 3.498 billion yen),
Operating profit was 5 billion won (approximately 583.05 million yen). Sales have doubled in about six years, and operating profit has more than doubled in two years.
The company's main products are the "Kanbo Donguiko" patch containing traditional Korean medicine and the "Lidocare Katapla" patch.
The company's name is Zuma. The company also handles original design and manufacturing (ODM) for clients' brands. In particular, the company has a 70% share of the Korean herbal patch market, far ahead of other companies.
The scale of the company is about 200 billion won (about 23.3217 billion yen), of which the scale of traditional Korean medicine compresses is estimated to be about 30 billion won. The reason why the company has been able to maintain its position as the top in the market for about 20 years since its establishment is that
Based on the know-how it has cultivated in providing transdermal drug delivery systems, the company has built up the capacity to design and produce transdermal drug delivery systems (TDDS) that have excellent absorption rates and stability.
The company stated, "Transdermal formulations have a high barrier to entry and business approval procedures are becoming more difficult. This gives us an advantage as we have our own technology and products."